Meta‐analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium‐glucose co‐transporter‐2 inhibitors; implications for COVID19 pandemic. – Wiley

Corresponding Author

Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece

Correspondence

Dimitrios Patoulias, MD, MSc, PhD (c), Second Propedeutic Department of Internal Medicine, General Hospital “Hippokration”, Konstantinoupoleos 49, 54642, Thessaloniki, Greece. Telephone number: +30‐6946900777, fax number: +30‐2310225083, e‐mail address: dipatoulias@gmail.com

Search for more papers by this author